MedPath

Evaluation of therapeutic effect on prostate cancer patients with bone metastases using Bone Scan Index (BSI)

Not Applicable
Recruiting
Conditions
Prostate cancer patients with bone metastasis
Registration Number
JPRN-UMIN000011648
Lead Sponsor
Osaka University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
160
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with difficulty in bone scintigraphy data analsysis due to the structural deformity or extraosseous uptake in bone scintigraphy 2. Patients corresponding to contraindication of Tc 99m methylene diphosphonate 3.Patient who were inappropriate for this study judged by medical doctor

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The change rate of BSI before and after treatment
Secondary Outcome Measures
NameTimeMethod
The correlation between change rate of BSI and SRE event rate The correlation between change rate of BSI and PSA, bone turnover markers
© Copyright 2025. All Rights Reserved by MedPath